Peng Long-kai, Yu Shao-jie, Yang Luo-yan, Xie Xu-biao, Peng Feng-hua, Yang Jin-rui, Zhao Xiao-kun, Chen Shan-qun, Liu Xian-ling
Department of Urology, Second Xiang-Ya Hospital of Central South University, Changsha 410011, China.
Zhonghua Yi Xue Za Zhi. 2007 Jul 24;87(28):1975-7.
To evaluate the long-term clinical effects of orthotopic ileal or sigmoidocolic neobladder.
One hundred and twenty six patients with bladder cancer who underwent radical cystectomy and orthotopic ileal or sigmoidocolic neobladder from 1989 to 2001 were followed up, the clinical data was collected and analysed. Hautmann orthotopic ileal neobladder was performed on 84 cases and orthotopic sigmoidocolic neobladder was performed on 42 cases; Lymph node clearing during surgery was performed on 62 cases, chemotherapy and radiotherapy was performed on 64 cases after surgery. The continence and complications were compared between sigmoidocolic group and ileal group, the tumor recurrent rate and the 5-year survival rate were compared between lymphnode clearing group and chemoradical therapy group.
Complete follow up was performed in 122 cases. Ureter broaden and urine backflow rate were higher in sigmoidocolic group than in ileal group (P < 0.05), nocturnal continence rate in sigmoidocolic group was higher than in ileal group (P < 0.05); Post-surgical tumor recurrent rate in lymphnode clearing group was lower than in chemoradical therapy group (P < 0.05), the 5-year survival rate in lymphnode clearing group was higher than in chemoradical therapy group (P < 0.05). The overall short-term complication rate was 15.9% (20/126), the overall long-term complication rate was 9.8% (12/122).
The effects of orthotopic ileal or sigmoidocolic neobladder were satisfactory with low complication rate, lymphnode clearing during the surgery can increase the 5-year survival rate when compared with the chemoradical group.
评估原位回肠或乙状结肠新膀胱的长期临床效果。
对1989年至2001年期间接受根治性膀胱切除术并原位回肠或乙状结肠新膀胱术的126例膀胱癌患者进行随访,收集并分析临床资料。84例行Hautmann原位回肠新膀胱术,42例行原位乙状结肠新膀胱术;62例术中行淋巴结清扫,64例术后行化疗和放疗。比较乙状结肠组和回肠组的控尿情况及并发症,比较淋巴结清扫组和放化疗组的肿瘤复发率及5年生存率。
122例患者获得完整随访。乙状结肠组输尿管增宽和尿液反流率高于回肠组(P<0.05),乙状结肠组夜间控尿率高于回肠组(P<0.05);淋巴结清扫组术后肿瘤复发率低于放化疗组(P<0.05),淋巴结清扫组5年生存率高于放化疗组(P<0.05)。总体短期并发症发生率为15.9%(20/126),总体长期并发症发生率为9.8%(12/122)。
原位回肠或乙状结肠新膀胱效果满意,并发症发生率低,与放化疗组相比,术中淋巴结清扫可提高5年生存率。